Abstract:Telocytes (TCs) were recently described as interstitial cells with very long prolongations named telopodes (Tps; ). Establishing the TC proteome is a priority to show that TCs are a distinct type of cells. Therefore, we examined the molecular aspects of lung TCs by comparison with fibroblasts (FBs). Proteins extracted from primary cultures of these cells were analysed by automated 2-dimensional nano-electrospray ionization liquid chromatography tandem mass spectrometry (2D Nano-ESI LC-MS/MS). Differentially expressed proteins were screened by two-sample t-test (P<0.05) and fold change (>2), based on the bioinformatics analysis. We identified hundreds of proteins up- or down-regulated, respectively, in TCs as compared with FBs. TC proteins with known identities are localized in the cytoskeleton (87%) and plasma membrane (13%), while FB up-regulated proteins are in the cytoskeleton (75%) and destined to extracellular matrix (25%). These identified proteins were classified into different categories based on their molecular functions and biological processes. While the proteins identified in TCs are mainly involved in catalytic activity (43%) and as structural molecular activity (25%), the proteins in FBs are involved in catalytic activity (24%) and in structural molecular activity, particularly synthesis of collagen and other extracellular matrix components (25%). Anyway, our data show that TCs are completely different from FBs. In conclusion, we report here the first extensive identification of proteins from TCs using a quantitative proteomics approach. Protein expression profile shows many up-regulated proteins e.g. myosin-14, periplakin, suggesting that TCs might play specific roles in mechanical sensing and mechanochemical conversion task, tissue homoeostasis and remodelling/renewal. Furthermore, up-regulated proteins matching those found in extracellular vesicles emphasize TCs roles in intercellular signalling and stem cell niche modulation. The novel proteins identified in TCs will be an important resource for further proteomic research and it will possibly allow biomarker identification for TCs. It also creates the premises for understanding the pathogenesis of some lung diseases involving TCs.

Telocytes and Lung Disease.

Potential Roles of Telocytes in Lung Diseases

Single‐cell RNA Sequencing Reveals Telocytes Subsets of Human Lung

Telocyte Morphologies and Potential Roles in Diseases

Telocytes In Regenerative Medicine

Differences in the expression of chromosome 1 genes between lung telocytes and other cells: mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells and lymphocytes

Telocytes in Trachea and Lungs

Potential Significance of Telocytes in the Pathogenesis of Lung Diseases

Genetic Comparison of Mouse Lung Telocytes with Mesenchymal Stem Cells and Fibroblasts

Telocytes in Liver: Electron Microscopic and Immunofluorescent Evidence

Telocytes: current methods of research, challenges and future perspectives

Comparative Proteomic Analysis of Human Lung Telocytes with Fibroblasts.

Hepatic Telocytes.

Global analyses of Chromosome 17 and 18 genes of lung telocytes compared with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes

Variations Of Chromosomes 2 And 3 Gene Expression Profiles Among Pulmonary Telocytes, Pneumocytes, Airway Cells, Mesenchymal Stem Cells And Lymphocytes

The History of Telocyte Discovery and Understanding.

Telocytes in Fibrosis Diseases: From Current Findings to Future Clinical Perspectives

Global comparison of chromosome X genes of pulmonary telocytes with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes

CD34+ stromal cells/telocytes and their role in mouse lung development: Light microscopy, immunofluorescence, ultrastructural and scanning electron microscopy evidence

Paracrine Endocrinology of Cardiac Telocytes in Culture

Comparison of Chromosome 4 Gene Expression Profile Between Lung Telocytes and Other Local Cell Types